These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 25857299

  • 1. Low spinophilin expression enhances aggressive biological behavior of breast cancer.
    Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, Wagner K, Langsenlehner T, Resel M, Gerger A, Ling H, Ivan C, Calin GA, Hoefler G, Rinner B, Pichler M.
    Oncotarget; 2015 May 10; 6(13):11191-202. PubMed ID: 25857299
    [Abstract] [Full Text] [Related]

  • 2. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
    Wu XS, Bao TH, Ke Y, Sun DY, Shi ZT, Tang HR, Wang L.
    Tumour Biol; 2016 Nov 10; 37(11):14711-14719. PubMed ID: 27623945
    [Abstract] [Full Text] [Related]

  • 3. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH, Wang Y, Yang JY, Li J, Feng MX, Wang YH, Yang XM, He P, Tian GA, Zhang XX, Li Q, Cao XY, Huo YM, Yang MW, Fu XL, Li J, Liu DJ, Dai M, Wen SY, Gu JR, Hong J, Hua R, Zhang ZG, Sun YW.
    Oncotarget; 2016 Jan 26; 7(4):4226-40. PubMed ID: 26735172
    [Abstract] [Full Text] [Related]

  • 4. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY, Cai JP, Liu X, Chen W, Hou X, Chen D, Lai JM, Liang LJ, Yin XY.
    Chin J Cancer; 2016 Jul 28; 35(1):70. PubMed ID: 27469137
    [Abstract] [Full Text] [Related]

  • 5. Decreased expression of SOX17 is associated with tumor progression and poor prognosis in breast cancer.
    Fu DY, Tan HS, Wei JL, Zhu CR, Jiang JX, Zhu YX, Cai FL, Chong MH, Ren CL.
    Tumour Biol; 2015 Sep 28; 36(10):8025-34. PubMed ID: 25971583
    [Abstract] [Full Text] [Related]

  • 6. Generation of MCF-7 cells with aggressive metastatic potential in vitro and in vivo.
    Ziegler E, Hansen MT, Haase M, Emons G, Gründker C.
    Breast Cancer Res Treat; 2014 Nov 28; 148(2):269-77. PubMed ID: 25292421
    [Abstract] [Full Text] [Related]

  • 7. Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma.
    Aigelsreiter A, Ress AL, Bettermann K, Schauer S, Koller K, Eisner F, Kiesslich T, Stojakovic T, Samonigg H, Kornprat P, Lackner C, Haybaeck J, Pichler M.
    Br J Cancer; 2013 May 14; 108(9):1830-7. PubMed ID: 23591196
    [Abstract] [Full Text] [Related]

  • 8. Exosomes enriched in stemness/metastatic-related mRNAS promote oncogenic potential in breast cancer.
    Rodríguez M, Silva J, Herrera A, Herrera M, Peña C, Martín P, Gil-Calderón B, Larriba MJ, Coronado MJ, Soldevilla B, Turrión VS, Provencio M, Sánchez A, Bonilla F, García-Barberán V.
    Oncotarget; 2015 Dec 01; 6(38):40575-87. PubMed ID: 26528758
    [Abstract] [Full Text] [Related]

  • 9. Significances of contactin-1 expression in human gastric cancer and knockdown of contactin-1 expression inhibits invasion and metastasis of MKN45 gastric cancer cells.
    Chen DH, Yu JW, Wu JG, Wang SL, Jiang BJ.
    J Cancer Res Clin Oncol; 2015 Dec 01; 141(12):2109-20. PubMed ID: 25952582
    [Abstract] [Full Text] [Related]

  • 10. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F, Zhang X, Meng J, Zhao Y, Liu X, Liu Y, Wang Y, Li Y, Sun Y, Wang Z, Mei Q, Zhang T.
    Oncotarget; 2015 Jun 30; 6(18):16239-52. PubMed ID: 25938545
    [Abstract] [Full Text] [Related]

  • 11. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis.
    Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL, Yang YC.
    Int J Cancer; 2014 Dec 01; 135(11):2593-603. PubMed ID: 24740680
    [Abstract] [Full Text] [Related]

  • 12. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H, Ren Y, Xu H, Pang D, Duan C, Liu C.
    Surg Oncol; 2013 Dec 01; 22(4):217-23. PubMed ID: 23992744
    [Abstract] [Full Text] [Related]

  • 13. Necdin is a breast cancer metastasis suppressor that regulates the transcription of c-Myc.
    Lee M, Beggs SM, Gildea D, Bupp S, Lichtenberg J, Trivedi NS, NISC Comparative Sequencing Program, Hu Y, Bodine DM, Crawford NP.
    Oncotarget; 2015 Oct 13; 6(31):31557-68. PubMed ID: 26384308
    [Abstract] [Full Text] [Related]

  • 14. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N, Zhang QY, Zou JL, Li ZW, Tian TT, Dong B, Liu XJ, Ge S, Zhu Y, Gao J, Shen L.
    Oncotarget; 2016 Jan 26; 7(4):4817-28. PubMed ID: 26716895
    [Abstract] [Full Text] [Related]

  • 15. Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling.
    Peng D, Tanikawa T, Li W, Zhao L, Vatan L, Szeliga W, Wan S, Wei S, Wang Y, Liu Y, Staroslawska E, Szubstarski F, Rolinski J, Grywalska E, Stanisławek A, Polkowski W, Kurylcio A, Kleer C, Chang AE, Wicha M, Sabel M, Zou W, Kryczek I.
    Cancer Res; 2016 Jun 01; 76(11):3156-65. PubMed ID: 27197152
    [Abstract] [Full Text] [Related]

  • 16. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y, Jin K, van Pelt GW, van Dam H, Yu X, Mesker WE, Ten Dijke P, Zhou F, Zhang L.
    Cancer Res; 2016 Jun 01; 76(11):3364-75. PubMed ID: 27197202
    [Abstract] [Full Text] [Related]

  • 17. Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer.
    Ress AL, Stiegelbauer V, Schwarzenbacher D, Deutsch A, Perakis S, Ling H, Ivan C, Calin GA, Rinner B, Gerger A, Pichler M.
    Oncotarget; 2014 Sep 30; 5(18):8492-502. PubMed ID: 25261368
    [Abstract] [Full Text] [Related]

  • 18. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
    AlHossiny M, Luo L, Frazier WR, Steiner N, Gusev Y, Kallakury B, Glasgow E, Creswell K, Madhavan S, Kumar R, Upadhyay G.
    Cancer Res; 2016 Jun 01; 76(11):3376-86. PubMed ID: 27197181
    [Abstract] [Full Text] [Related]

  • 19. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM.
    Int J Cancer; 2009 Sep 15; 125(6):1343-51. PubMed ID: 19533747
    [Abstract] [Full Text] [Related]

  • 20. SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer.
    Song Y, Zhang J, Tian T, Fu X, Wang W, Li S, Shi T, Suo A, Ruan Z, Guo H, Yao Y.
    Tumour Biol; 2016 Jul 15; 37(7):9311-22. PubMed ID: 26779630
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.